FdaApplication

ANDA 211396

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS LLC
application_typeANDA
approval_date2020-09-28

Products (5)

ProductActive ingredientStrengthDosage form
ESTRADIOLESTRADIOL0.025MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
ESTRADIOLESTRADIOL0.05MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
ESTRADIOLESTRADIOL0.0375MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
ESTRADIOLESTRADIOL0.1MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
ESTRADIOLESTRADIOL0.075MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL

5 products